Literature DB >> 21195933

Guidelines for vitamin supplements in chronic kidney disease patients: what is the evidence?

Garry J Handelman1, Nathan W Levin.   

Abstract

Wide discrepancies exist in the use of vitamins in kidney disease, and evidence-based recommendations are sparse. Water-soluble vitamin levels may be inadequate in patients not receiving supplements and this may be associated with increased mortality, which deserves further attention to increase strength of evidence. Supplements should be administered cautiously as renal mechanisms to prevent hypervitaminosis are no longer functional. The most reliable assays for vitamin status examine tissue mechanisms that rely on vitamins as cofactors. Vitamin A levels are generally quite high, vitamin D is low and requires supplementation, and the benefits of vitamin E may be linked to its usage in a modified dialysis membrane. Because of restricted diets that provide limited vitamin intake from food, many renal patients can benefit from a tablet that adds an amount equal to one recommended daily allowance of water-soluble vitamins, but larger amounts are not appropriate or beneficial. Vitamin status is influenced by interaction of many variables, and individual attention to each patient is warranted to achieve optimal vitamin status.
Copyright © 2011 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21195933     DOI: 10.1053/j.jrn.2010.11.004

Source DB:  PubMed          Journal:  J Ren Nutr        ISSN: 1051-2276            Impact factor:   3.655


  5 in total

1.  Circulating vitamin E and cardiometabolic measures: a Mendelian randomization analysis.

Authors:  Chuanlong Fan; Tao Huang; Xuejun Kong; Xiaohong Zhang; Zuquan Zou; Jing Xiao
Journal:  J Clin Biochem Nutr       Date:  2019-08-09       Impact factor: 3.114

2.  Novel associations between blood metabolites and kidney function among Bogalusa Heart Study and Multi-Ethnic Study of Atherosclerosis participants.

Authors:  Jovia L Nierenberg; Jiang He; Changwei Li; Xiaoying Gu; Mengyao Shi; Alexander C Razavi; Xuenan Mi; Shengxu Li; Lydia A Bazzano; Amanda H Anderson; Hua He; Wei Chen; Jason M Kinchen; Casey M Rebholz; Josef Coresh; Andrew S Levey; Lesley A Inker; Michael Shlipak; Tanika N Kelly
Journal:  Metabolomics       Date:  2019-11-13       Impact factor: 4.290

3.  Sevelamer Use in End-Stage Kidney Disease (ESKD) Patients Associates with Poor Vitamin K Status and High Levels of Gut-Derived Uremic Toxins: A Drug-Bug Interaction?

Authors:  Lu Dai; Björn K Meijers; Bert Bammens; Henriette de Loor; Leon J Schurgers; Abdul Rashid Qureshi; Peter Stenvinkel; Pieter Evenepoel
Journal:  Toxins (Basel)       Date:  2020-05-27       Impact factor: 4.546

4.  Protective and therapeutic effects of licorice in rats with acute tubular necrosis.

Authors:  Nurten Aksoy; Yunus Dogan; Mehmet Iriadam; Muharrem Bitiren; Elmas Uzer; Abdullah Ozgonul; Sahin Aksoy
Journal:  J Ren Nutr       Date:  2011-11-01       Impact factor: 3.655

5.  Assessment of Dietary Folate Intake and Pill Burden among Saudi Patients on Maintenance Hemodialysis.

Authors:  Ibrahim Sales; Ghada Bawazeer; Ahmad R Tarakji; Feriel K Ben Salha; Nourah H Al-Deaiji; Marwah Saeed; Rawan S Idris; Mohammad H Aljawadi; Majidah A Aljohani; Mansour Adam Mahmoud; Wajid Syed
Journal:  Int J Environ Res Public Health       Date:  2021-12-02       Impact factor: 3.390

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.